openPR Logo
Press release

Demand for Vancomycin To Expand At A CAGR of 5.8% Over 2027

11-11-2022 05:23 AM CET | Health & Medicine

Press release from: fact.mr

Vancomycin

Vancomycin

The global vancomycin market is projected to increase from a valuation of US$ 313.7 Mn in 2020 to US$ 465.1 Mn by the end of 2027. Demand for vancomycin to expand at a CAGR of 5.8% during the forecast period.

Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.

The global vancomycin market is being driven by increased incidence of diseases caused by vancomycin-resistant Staphylococcus aureus (VRSA), and poor sanitation, which, in turn, increases the risk of hospital-acquired infections.
VRSA infections can be treated with a range of commercially available drugs, but maintaining basic sanitary conditions, including wound care, hand washing before and after direct contact with patients, and the use of disposable gloves, is the most effective strategy for preventing the spread of VRSA.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7293

Key Takeaways from Vancomycin Market Study

• Global vancomycin market to reach US$ 465.1 valuation Mn by 2027.

• Market in Germany projected to rise at a CAGR of 4% over the forecast period.

• Market in Canada to record 4.6% CAGR over the forecast period of 2021-2027.

• China vancomycin market forecast to reach size of US$ 102.3 Mn by 2027.

What Might Restrain Demand for Vancomycin to Some Extent?

"Rising Use of Generic Alternatives & Certain Side Effects Hampering Market Value"

Two typical adverse drug reactions associated with IV vancomycin are severe local pain and thrombophlebitis (which affect about 1% of patients). Clinical experiments conducted in the mid-1950s revealed that early impure versions of vancomycin tablets caused kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Nephrotoxicity was discovered to be a rare adverse effect in later investigations using purer forms of vancomycin (0.1% to 1% of patients).
Certain limitations, such as rising use of generic alternatives, particularly as patents expire, and short lifecycle of medications, are expected to hinder vancomycin market growth.

To learn more about Vancomycin Market, you can get in touch with our Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7293

Key Companies Profiled by Fact.MR

• Alvogen
• MGB Biopharma Limited
• Oragenics
• Aphios Corporation
• Microbiotix

Key Segments Covered in Vancomycin Industry Research

• Vancomycin Market by Type :

o Daptomycin
o Linezolid
o Quinupristin
o Ampicillin
o Chloramphenicol
o Others

• Vancomycin Market by Application :

o Sepsis
o Lung Infection
o Skin Soft Tissue Infection
o Colitis & Intestinal Inflammation
o Other Infections

• Vancomycin Market by Region :

o North America Vancomycin Market
o Europe Vancomycin Market
o Asia Pacific Vancomycin Market
o Latin America Vancomycin Market
o MEA Vancomycin Market

Get Free Access to this Report :

https://www.factmr.com/checkout/7293

Questionnaire answered in the Vancomycin Market report include:

• How the market for Vancomycin has grown?
• What is the present and future outlook of the global Vancomycin on the basis of region?
• What are the challenges and opportunities for the Vancomycin?
• Why the consumption of Vancomycin highest in region?
• In which year segment is expected to overtake segment?

Table of Content

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product modifications /Innovation

4. Key Success Factors

4.1. Strategic Developments
4.2. Key regulations
4.3. Product USPs /Technology

Contd…

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed . Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Demand for Vancomycin To Expand At A CAGR of 5.8% Over 2027 here

News-ID: 2802789 • Views:

More Releases from fact.mr

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Vancomycin

Vancomycin Hydrochloride for Injection Market Size And Global Industry Forecast …
" The global market for Vancomycin Hydrochloride for Injection is valued at approximately $860 million in 2024, with a projected increase to around $1.4 billion by the end of 2034. This represents a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Vancomycin Hydrochloride for Injection Market". This report covers the global Vancomycin Hydrochloride for Injection
Global Vancomycin for Home Infusion Market Growth Forecast Report 2025-2031
On Mar 9, 2025, Global Info Research released a research report titled "Global Vancomycin for Home Infusion Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Vancomycin for Home Infusion market from 2020 to 2031. Including the market size and development trends of Vancomycin for Home Infusion Market, it analyzes market size indicators such as sales, sales volume, average price
Vancomycin Hydrochloride Manufacturing Project Cost: Industry Trends and Raw Mat …
Setting up a vancomycin hydrochloride plant facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Vancomycin Hydrochloride Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a vancomycin hydrochloride
Impact Of Rising Infectious Disease Prevalence On The Vancomycin Market Driver: …
What Are the Projected Growth and Market Size Trends for the Vancomycin Market? There has been a swift expansion in the size of the vancomycin market in the past few years. The market, which was valued at $0.82 billion in 2024, is projected to reach $0.92 billion by 2025, boasting a compound annual growth rate (CAGR) of 11.5%. The significant growth experienced in the historical period is credited to factors
Vancomycin Market to see Rapid Growth by 2029
Vancomycin Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of % from 2024 to 2030. The Vancomycin market is witnessing significant growth, driven by its critical role in treating severe bacterial infections. As a potent antibiotic, Vancomycin is widely used to combat infections caused by Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus). With the increasing prevalence of
Vancomycin Market Latest Trend and Development 2020-2026
The Vancomycin Market research report consists of market analysis, growth, trends, forecast, and comprehensive strategies in the future. It also assists with strategic and planning decisions that incorporate the necessary information to perform PEST, SWOT, and STEER analysis. Moreover, the Vancomycin Market report analyzes the critical performance and operational metrics so that you can plan robust business strategies. Download a FREE Sample Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4800576 The report consists a detailed analysis of